RCUS icon

Arcus Biosciences

184 hedge funds and large institutions have $1.36B invested in Arcus Biosciences in 2022 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 81 increasing their positions, 54 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding in top 10

Funds holding in top 10:

more funds holding

Funds holding:

3% more capital invested

Capital invested by funds: $1.33B → $1.36B (+$35.9M)

0.4% less ownership

Funds ownership: 73.13%72.73% (-0.4%)

11% less call options, than puts

Call options by funds: $4.87M | Put options by funds: $5.46M

Holders
184
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$4.87M
Puts
$5.46M
Net Calls
Net Calls Change

Top Buyers

1 +$21.1M
2 +$17.4M
3 +$9.98M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$9.4M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$4.55M

Top Sellers

1 -$32.5M
2 -$11.1M
3 -$10.3M
4
State Street
State Street
Massachusetts
-$7.69M
5
Morgan Stanley
Morgan Stanley
New York
-$6.03M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$1.14M
77
$1.11M
78
$1.1M
79
$1.05M
80
$1.04M
81
$1.03M
82
$1.02M
83
$1.01M
84
$978K
85
$949K
86
$940K
87
$929K
88
$885K
89
$872K
90
$852K
91
$804K
92
$788K
93
$781K
94
$759K
95
$744K
96
$737K
97
$719K
98
$704K
99
$695K
100
$693K